BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 7, 2004
View Archived Issues
Caspase inhibitor reduces platelet function and aggregation in rats
Read More
Suppression of testosterone by abiraterone acetate in prostate cancer patients
Read More
New evidence on the association between Lp-PLA2 and the risk of CHD and stroke
Read More
Clinical benefits of mepolizumab in eosinophilic skin disorders
Read More
Characterization of the antiinflammatory effects of topical tacrolimus in atopic dermatitis
Read More
NV-1020 enters phase I/II study for liver metastases
Read More
Serono concludes licensing agreement
Read More
New antibacterial LpxC inhibitors identified at Chiron
Read More
Fujisawa presents novel PDE4 and TNF-alpha production inhibitors
Read More
FDA response for Lyrica
Read More
Novel adenosine A2A antagonists and their use in depression, AD, PD, etc.
Read More
CV scientists describe novel fatty acid oxidation inhibitors
Read More
Proscar approved for new indication in Canada
Read More
New prostanoid EP4 agonists and their use in osteoporosis and other bone disorders
Read More
Novel urea-based immunomodulators discovered at Genzyme
Read More
Fujisawa claims new HDAC inhibitors for immune disorders, cancer, etc.
Read More
Novel DPP-IV inhibitor BMS-477118 shows potential for type 2 diabetes
Read More
sBLA filed for Pegasys plus Copegus in HCV patients coinfected with HIV
Read More
Fujisawa to submit new data for micafungin in Europe
Read More
Phase Ib study completed for ThromboView
Read More
Affymax updates pipeline
Read More
BIBN-4096BS reveals viability of CGRP receptor antagonism in headache
Read More
GW-766994 inhibits early and late phase allergic reactions
Read More
MethylGene reviews second quarter progress
Read More
Novartis makes good progress on key development projects during H1 2004
Read More
New data on the pharmacokinetics of Oralin in type 1 diabetes
Read More
An interim analysis provides new evidence of the efficacy of CJC-1131 in type 2 diabetes
Read More
Amlodipine/atorvastatin pill effective in diabetics with hypertension and dyslipidemia
Read More
Good safety and pharmacokinetic profile of tanaproget in healthy women
Read More
Procter & Gamble describes novel orally bioavailable caspase-1 inhibitor
Read More